| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |